RAPP insider filings

Rapport Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-03. Screen RAPP transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 15 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
HEALY JAMES — Director14 legs · 969,480 sh · $20,359,080——
Yeleswaram Krishnaswamy — Chief Development Officer1—3 legs · 50,160 sh · $2,531,582—
Ceesay Abraham — Chief Executive Officer, Director5—9 legs · 36,073 sh · $1,606,741—
PAUL STEVEN M — Director11 leg · 35,714 sh · $974,278——
Gault Cheryl — Chief Operating Officer1—2 legs · 10,000 sh · $331,856—
MARAGANORE JOHN — Director12 legs · 9,411 sh · $248,891——
Ignelzi Troy A. — Chief Financial Officer11 leg · 5,500 sh · $143,550——
Young Wendy B. — Director11 leg · 3,789 sh · $99,992——
Silva Paul M — Director11 leg · 3,680 sh · $99,636——
Sanchez Ramiro — Director11 leg · 3,600 sh · $98,478——

+1 more insider in the window, not shown — every filing appears in the table below.

Recent insider filings — Rapport Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-034Third Rock Ventures V, L.P. — Director, 10% owner
Third Rock Ventures GP V, LP — Director, 10% owner
TRV GP V, LLC — Director, 10% owner
Third Rock Ventures VI, L.P. — Director, 10% owner
Third Rock Ventures GP VI, L.P. — Director, 10% owner
TRV GP VI, LLC — Director, 10% owner
Grant/award (A): 238,095 @ $21 · Grant/award (A): 1,190,476 @ $21EDGAR
2026-10-304HEALY JAMES — DirectorPurchase (P): 952,380 @ $21 · Purchase (P): 6,395 @ $21 · Purchase (P): 3,772 @ $21 · Purchase (P): 6,933 @ $21EDGAR
2026-10-234Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 2,210 @ $29.16EDGAR
2026-10-234Sanchez Ramiro — DirectorPurchase (P): 3,600 @ $27.35EDGAR
2026-10-224Young Wendy B. — DirectorPurchase (P): 3,789 @ $26.39EDGAR
2026-10-224Silva Paul M — DirectorPurchase (P): 3,680 @ $27.07EDGAR
2026-10-224MARAGANORE JOHN — DirectorPurchase (P): 8,239 @ $26.38 · Purchase (P): 1,172 @ $26.92EDGAR
2026-10-224PAUL STEVEN M — DirectorPurchase (P): 35,714 @ $27.28EDGAR
2026-10-214Ignelzi Troy A. — Chief Financial OfficerPurchase (P): 5,500 @ $26.10EDGAR
2026-10-084Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 3,375 @ $32.03 · Sale (S): 1,147 @ $30.66EDGAR
2026-10-014Gault Cheryl — Chief Operating OfficerSale (S): 7,925 @ $33.04 · Sale (S): 2,075 @ $33.76EDGAR
2026-09-244Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 1,952 @ $39.05 · Sale (S): 215 @ $39.86 · Sale (S): 43 @ $41.05EDGAR
2026-09-094Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 7,141 @ $45.55 · Sale (S): 1,069 @ $46.01EDGAR
2026-08-264Yeleswaram Krishnaswamy — Chief Development OfficerSale (S): 13,160 @ $50.00 · Sale (S): 20,799 @ $50.31 · Sale (S): 16,201 @ $51.06EDGAR
2026-08-264Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 18,921 @ $49.57EDGAR
2026-08-204Yeleswaram Krishnaswamy — Chief Development OfficerSale (S): 404 @ $49.90EDGAR
2026-08-124Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 14,171 @ $45.97 · Sale (S): 8,370 @ $46.75 · Sale (S): 3,664 @ $46.90 · Sale (S): 19,500 @ $48.04 · Sale (S): 5,794 @ $48.62EDGAR
2026-07-294Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 2,203 @ $42.11 · Sale (S): 7 @ $42.73EDGAR
2026-07-154Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 5,481 @ $39.72 · Sale (S): 2,729 @ $40.57EDGAR
2026-07-014Gault Cheryl — Chief Operating OfficerSale (S): 1,900 @ $40.09 · Sale (S): 3,792 @ $41.39 · Sale (S): 3,308 @ $42.17 · Sale (S): 1,000 @ $43.15EDGAR
2026-07-014Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 7,344 @ $39.77 · Sale (S): 876 @ $40.34EDGAR
2026-06-104Young Wendy B. — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-104Sanchez Ramiro — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-104Huber Reid M — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-104Silva Paul M — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-104PEREZ ROBERT J — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-104HEALY JAMES — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-104PAUL STEVEN M — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-104MARAGANORE JOHN — DirectorGrant/award (A): 15,200 (derivative) @ $0EDGAR
2026-05-284Third Rock Ventures V, L.P. — 10% owner
Third Rock Ventures GP V, LP — 10% owner
TRV GP V, LLC — 10% owner
Third Rock Ventures VI, L.P. — 10% owner
Third Rock Ventures GP VI, L.P. — 10% owner
TRV GP VI, LLC — 10% owner
Sale (S): 18,572 @ $40.05EDGAR
2026-05-134Third Rock Ventures V, L.P. — 10% owner
Third Rock Ventures GP V, LP — 10% owner
TRV GP V, LLC — 10% owner
Third Rock Ventures VI, L.P. — 10% owner
Third Rock Ventures GP VI, L.P. — 10% owner
TRV GP VI, LLC — 10% owner
Sale (S): 133,618 @ $40.24EDGAR
2026-05-114Third Rock Ventures V, L.P. — 10% owner
Third Rock Ventures GP V, LP — 10% owner
TRV GP V, LLC — 10% owner
Third Rock Ventures VI, L.P. — 10% owner
Third Rock Ventures GP VI, L.P. — 10% owner
TRV GP VI, LLC — 10% owner
Sale (S): 271,495 @ $40.12 · Sale (S): 5,018 @ $40.31EDGAR
2026-04-214Yeleswaram Krishnaswamy — Chief Development OfficerSale (S): 20,225 @ $39.99EDGAR
2026-04-214Third Rock Ventures V, L.P. — 10% owner
Third Rock Ventures GP V, LP — 10% owner
TRV GP V, LLC — 10% owner
Third Rock Ventures VI, L.P. — 10% owner
Third Rock Ventures GP VI, L.P. — 10% owner
TRV GP VI, LLC — 10% owner
Sale (S): 426,005 @ $40.32EDGAR
2026-04-144Yeleswaram Krishnaswamy — Chief Development OfficerSale (S): 500 @ $34.98 · Sale (S): 9,165 @ $34.97 · Sale (S): 10,200 @ $35.08EDGAR
2026-04-094Yeleswaram Krishnaswamy — Chief Development OfficerSale (S): 360 @ $34.90EDGAR
2026-03-314Gault Cheryl — Chief Operating OfficerSale (S): 7,161 @ $28.04 · Sale (S): 2,839 @ $28.55EDGAR
2026-03-264Yeleswaram Krishnaswamy — Chief Development OfficerSale (S): 10,115 @ $29.99EDGAR
2026-03-094Gault Cheryl — Chief Operating OfficerSale (S): 2,014 @ $28.93EDGAR
2026-02-194Bredt David — Chief Scientific OfficerSale (S): 900 @ $28.02 · Sale (S): 5,400 @ $28.95 · Sale (S): 2,200 @ $29.59 · Option exercise (M): 6,000 @ $1.80 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2026-02-194Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 3,552 @ $29.05 · Sale (S): 2,281 @ $29.80 · Sale (S): 2,983 @ $29.04 · Sale (S): 2,100 @ $29.80EDGAR
2026-02-044Yeleswaram Krishnaswamy — Chief Development OfficerGrant/award (A): 120,000 (derivative) @ $0EDGAR
2026-02-044Bredt David — Chief Scientific OfficerGrant/award (A): 103,000 (derivative) @ $0EDGAR
2026-02-044Gault Cheryl — Chief Operating OfficerGrant/award (A): 132,000 (derivative) @ $0EDGAR
2026-02-044Sevigny Jeffrey — Chief Medical OfficerGrant/award (A): 130,000 (derivative) @ $0EDGAR
2026-02-044Ceesay Abraham — Chief Executive Officer, DirectorGrant/award (A): 428,000 (derivative) @ $0EDGAR
2026-02-044Ignelzi Troy A. — Chief Financial OfficerGrant/award (A): 148,000 (derivative) @ $0EDGAR
2026-01-224Ceesay Abraham — Chief Executive Officer, DirectorSale (S): 5,833 @ $26.12 · Sale (S): 5,083 @ $26.11EDGAR
2026-01-164Bredt David — Chief Scientific OfficerSale (S): 8,300 @ $26.83 · Sale (S): 200 @ $27.40EDGAR
2026-01-054Yeleswaram Krishnaswamy — Chief Development OfficerGrant/award (A): 9,000 · Sale (S): 2,840 @ $30.05EDGAR

Recent 8-K events — Rapport Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-308-K1.01 — Entry into a Material Definitive Agreement
2.02 — Results of Operations and Financial Condition
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-208-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-108-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-218-K7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2026-03-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RAPP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs